Emergent BioSolutions Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Emergent BioSolutions Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q2 2024.
  • Emergent BioSolutions Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$283M, a 8.3% decline year-over-year.
  • Emergent BioSolutions Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$587M, a 2.44% increase year-over-year.
  • Emergent BioSolutions Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$761M, a 259% decline from 2022.
  • Emergent BioSolutions Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$212M, a 196% decline from 2021.
  • Emergent BioSolutions Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $220M, a 28.2% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$587M -$283M -$21.7M -8.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$565M $9M +$195M Jan 1, 2024 Mar 31, 2024 10-Q 2024-08-07
Q4 2023 -$761M -$49.5M +$17.5M +26.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-08
Q3 2023 -$778M -$263M -$176M -202% Jul 1, 2023 Sep 30, 2023 10-Q 2023-12-11
Q2 2023 -$602M -$261M -$209M -394% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$393M -$186M -$182M -3948% Jan 1, 2023 Mar 31, 2023 10-Q 2024-08-07
Q4 2022 -$212M -$67M -$260M -135% Oct 1, 2022 Dec 31, 2022 10-K/A 2023-12-11
Q3 2022 $48.5M -$87.1M -$46.7M -116% Jul 1, 2022 Sep 30, 2022 10-Q 2023-12-11
Q2 2022 $95.2M -$52.9M -$52.4M -10480% Apr 1, 2022 Jun 30, 2022 10-Q 2023-12-11
Q1 2022 $148M -$4.6M -$71.9M -107% Jan 1, 2022 Mar 31, 2022 10-Q 2023-12-11
Q4 2021 $220M $193M +$7.7M +4.15% Oct 1, 2021 Dec 31, 2021 10-K/A 2023-12-11
Q3 2021 $212M -$40.4M -$79.9M -202% Jul 1, 2021 Sep 30, 2021 10-K/A 2023-12-11
Q2 2021 $292M -$500K -$93.2M -101% Apr 1, 2021 Jun 30, 2021 10-K/A 2023-12-11
Q1 2021 $385M $67.3M +$79.8M Jan 1, 2021 Mar 31, 2021 10-K/A 2023-12-11
Q4 2020 $305M $185M +$139M +295% Oct 1, 2020 Dec 31, 2020 10-K 2021-02-19
Q3 2020 $167M $39.5M -$3.7M -8.57% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $170M $92.7M +$102M Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $68.1M -$12.5M +$13.6M +52.1% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $54.5M $46.9M +$50.3M Oct 1, 2019 Dec 31, 2019 10-K 2021-02-19
Q3 2019 $4.2M $43.2M +$22.3M +107% Jul 1, 2019 Sep 30, 2019 10-K 2021-02-19
Q2 2019 -$18.1M -$9.5M -$59.6M -119% Apr 1, 2019 Jun 30, 2019 10-K 2021-02-19
Q1 2019 $41.5M -$26.1M -$21.2M -433% Jan 1, 2019 Mar 31, 2019 10-K 2021-02-19
Q4 2018 $62.7M -$3.4M -$37.3M -110% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-25
Q3 2018 $100M $20.9M -$12.7M -37.7% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-25
Q2 2018 $113M $50.1M +$45.5M +985% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-25
Q1 2018 $67.2M -$4.9M -$15.4M -147% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-25
Q4 2017 $82.6M $33.9M -$3.47M -9.27% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-25
Q3 2017 $86.1M $33.6M +$12.2M +57.2% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $73.9M $4.62M +$15.6M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $58.3M $10.5M +$6.49M +163% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-04
Q4 2016 $51.8M $37.4M +$4.07M +12.2% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-22
Q3 2016 $47.7M $21.3M -$15.6M -42.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-03
Q2 2016 $63.3M -$10.9M -$25M -178% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-04
Q1 2016 $88.4M $3.99M +$25.5M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 $62.9M $33.3M +$3.23M +10.7% Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 $59.6M $36.9M +$15.1M +69.2% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $44.5M $14.1M +$9.07M +180% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-05
Q1 2015 $35.5M -$21.5M -$1.28M -6.35% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $36.7M $30.1M +$14.9M +97.8% Oct 1, 2014 Dec 31, 2014 10-K 2016-02-29
Q3 2014 $21.8M $21.8M +$8.34M +61.8% Jul 1, 2014 Sep 30, 2014 10-K 2016-02-29
Q2 2014 $13.5M $5.03M -$5.46M -52% Apr 1, 2014 Jun 30, 2014 10-K 2016-02-29
Q1 2014 $19M -$20.2M -$12.2M -151% Jan 1, 2014 Mar 31, 2014 10-K 2016-02-29
Q4 2013 $31.1M $15.2M -$882K -5.48% Oct 1, 2013 Dec 31, 2013 10-K/A 2015-03-09
Q3 2013 $32M $13.5M +$6.87M +104% Jul 1, 2013 Sep 30, 2013 10-K/A 2015-03-09
Q2 2013 $25.1M $10.5M +$2.85M +37.4% Apr 1, 2013 Jun 30, 2013 10-K/A 2015-03-09
Q1 2013 $22.3M -$8.06M -$1.23M -18.1% Jan 1, 2013 Mar 31, 2013 10-K/A 2015-03-09
Q4 2012 $23.5M $16.1M -$12.6M -43.8% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-10
Q3 2012 $36.1M $6.62M +$5.07M +327% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-10
Q2 2012 $31M $7.63M -$6.58M -46.3% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-10
Q1 2012 $37.6M -$6.83M +$14.6M +68.1% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-10
Q4 2011 $23M $28.7M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-08
Q3 2011 $1.55M -$11.6M -88.2% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-08
Q2 2011 $14.2M +$4.4M +44.9% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-08
Q1 2011 -$21.4M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-08
Q3 2010 $13.1M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 $9.81M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.